Our commitment to clinical research stems from our commitment to patients.

Renal Denervation (RDN) treatment is not yet commercially available in the United States. It is being studied in a series of carefully designed, rigorous clinical trials and is commercially available in select centers outside the United States. These studies are focused on establishing the safety and effectiveness of the system in reducing blood pressure in patients with uncontrolled hypertension.

If you are a patient whose hypertension is not being adequately controlled with medication and are interested in potentially participating in one of our trials, ask your physician if they are aware of enrolling centers in your area. For more information about our US clinical trial, you may visit www.symplifyBPtrial.com.

You can also check back to this website and www.clinicaltrials.gov  for the most up-to-date information about our ongoing clinical studies.